Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

HER2 receptor tyrosine kinase inhibitors synthesized at Takeda

April 8, 1998

Zadaxin in combination with TACE shows promise in liver cancer therapy

April 8, 1998

Genta announces issue of patent for lead antisense compound

April 8, 1998

Orphan Medical announces results of Busulfex clinical trials

April 7, 1998

Novel apoptosis-related protease disclosed by Genetics Institute

April 7, 1998

More protein tyrosine kinase inhibitors in the pipeline at Glaxo Wellcome

April 7, 1998

New U.S. patent provides further protection for Onconase and related products

April 6, 1998

Protein tyrosine kinase inhibitors emerge from R&D at Glaxo Wellcome

April 6, 1998

TER-199 resistance-modulating mechanisms explored

April 6, 1998

CGP-60474: selective protein tyrosine kinase inhibitor for cancer

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...